本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ionis Pharmaceuticals, Inc

47.03
-4.4100-8.57%
成交量:452.38萬
成交額:2.18億
市值:78.16億
市盈率:-13.51
高:51.16
開:51.16
低:46.85
收:51.44
52周最高:86.74
52周最低:46.85
股本:1.66億
流通股本:1.62億
量比:1.02
換手率:2.79%
股息:- -
股息率:- -
每股收益(TTM):-3.4800
每股收益(LYR):-2.3812
淨資產收益率:-105.50%
總資產收益率:-12.42%
市淨率:17.77
市盈率(LYR):-19.75

資料載入中...

2025/01/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/20

重要事件披露

Form 8-K - Current report
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities